Liquid-liquid separation and chemical extraction are key processes in drug manufacturing and many other industries, including oil and gas, fragrances, food, wastewater filtration, and biotechnology.

November 17, 2009 (Orlando, Florida) — Advanced heart-failure transplant-ineligible patients with Thoratec's HeartMate II continuous-flow left-ventricular assist device (LVAD) have better-than-even ...

Based in Tampa, Florida, Virginia Pelley is a former women's magazine editor who has written health and fitness content for Men's Journal, Cosmopolitan magazine, the Chicago Tribune, ...

A continuous-flow left ventricular assist device (LVAD) improved survival free from disabling stroke compared with a pulsatile LVAD, when used as destination therapy over a 2-year period in patients ...

The study involved 7 children weighing 8 kg to 30 kg; all children survived, 5 to transplant and 1 to recovery. HealthDay News — The Jarvik 2015 left ventricular assist device (LVAD) seems promising ...

Left ventricular assist devices (LVADs) can improve survival in patients with severe heart failure (HF), but traditional pulsatile volume-displacement devices have considerable limitations. New ...

Two Houston surgeons have successfully implanted the world's first continuous-flow artificial heart in a human patient, a significant advance that promises a smaller and much more durable alternative ...

VADs are usually classified according to the mode of blood flow, namely pulsatile or continuous. Continuous types can be further subdivided based on the biomechanics of the pump: centrifugal or axial.

Phoenix, AZ, (May 18, 2023) - Findings from the first-in-human trial of a novel percutaneous ventricular assist device (pVAD) were presented today as late-breaking clinical research at the Society for ...

Earlier this month, the first fully implantable artificial heart was approved by the Food and Drug Administration. It brings hope to patients who are near death from heart failure; yet some major ...

In two interim analyses of this trial, patients with advanced heart failure who were treated with a fully magnetically levitated centrifugal-flow left ventricular assist device were less likely to ...